Tanya Moore
Investment Principal, Cancer Research Horizons
Dr Tanya Moore has extensive translation and commercialisation experience across therapeutics, diagnostics and medtech, including licensing, industry-academic alliances, and the formation of start-up companies. As Investment Principal at Cancer Research Horizons, Tanya leads its dedicated Ventures team, creating and investing in early-stage oncology companies through the Cancer Research Horizons Seed Fund, and manages its start-up portfolio.
Events Tanya Moore has spoken at
- BioTrinity 2026 14 April 2026 – 15 April 2026